Introduction: Recent years has witnessed major paradigm shifts in the treatment of NSCLC with the emergence of biomarkers and targeted therapies. Most importantly, ALK is a validated biomarker and its inhibition using targeted therapies have had significant effects on patients suffering from NSCLC. However, emergence of drug resistance has limited the usage of these agents in the patients. Objective: In the present objective, e-pharmacophore based virtual screening was employed to discover potent ALK inhibitors from a natural compound database, TIPdb. Result: Screening of TIPdb using the e-pharmacophore model (DDRRR) retrieved 1000 hits. The docking procedures and ADME analysis led to the identification of piperphilippinin VI as the best hit. Further interaction analysis showed that piperphilippinin VI exhibited crucial interactions with kinase domain of the protein, which is the major targeting site for ALK inhibitors. Note that, PASS prediction analysis highlighted the presence of anti-neoplastic activity of the hit molecule towards lung cancer in particular NSCLC. Conclusion: The comprehensive analysis of the present study shows that, piperphilippinin VI has higher binding affinity, low toxicity profiles and increased CNS activity. We believe that these observations are of immense importance in the rational designing of a novel and potent ALK inhibitors from natural sources.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.